Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia
Clinical trial NCT01251809 · TERMINATED
Trial details
- NCT number
- NCT01251809
- Sponsor
- medac GmbH
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-10-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.